AI Article Synopsis

  • The study investigates the interaction between Argonaute 2 (AGO2) and a protein called PSMC3, which is essential for RNA interference (RNAi) in humans.
  • Researchers used a yeast two-hybrid system to identify PSMC3 as a novel binding partner of AGO2, revealing that this interaction does not require RNA and is dependent on a specific region of PSMC3.
  • Results showed that PSMC3 not only stabilizes AGO2 by preventing its degradation via ubiquitination but also enhances its expression, indicating a crucial role in regulating AGO2 activity within the RNAi pathway.

Article Abstract

Background: Argonaute 2 (AGO2), the only protein with catalytic activity in the human Argonaute family, is considered as a key component of RNA interference (RNAi) pathway. Here we performed a yeast two-hybrid screen using the human Argonaute 2 PIWI domain as bait to screen for new AGO2-interacting proteins and explored the specific mechanism through a series of molecular biology and biochemistry experiments.

Methods: The yeast two-hybrid system was used to screen for AGO2-interacting proteins. Co-immunoprecipitation and immunofluorescence assays were used to further determine interactions and co-localization. Truncated plasmids were constructed to clarify the interaction domain. EGFP fluorescence assay was performed to determine the effect of PSMC3 on RNAi. Regulation of AGO2 protein expression and ubiquitination by PSMC3 and USP14 was examined by western blotting. RT-qPCR assays were applied to assess the level of AGO2 mRNA. Rescue assays were also performed.

Results: We identified PSMC3 (proteasome 26S subunit, ATPase, 3) as a novel AGO2 binding partner. Biochemical and bioinformatic analysis demonstrates that this interaction is performed in an RNA-independent manner and the N-terminal coiled-coil motif of PSMC3 is required. Depletion of PSMC3 impairs the activity of the targeted cleavage mediated by small RNAs. Further studies showed that depletion of PSMC3 decreased AGO2 protein amount, whereas PSMC3 overexpression increased the expression of AGO2 at a post-translational level. Cycloheximide treatment indicated that PSMC3 depletion resulted in a decrease in cytoplasmic AGO2 amount due to an increase in AGO2 protein turnover. The absence of PSMC3 promoted ubiquitination of AGO2, resulting in its degradation by the 26S proteasome. Mechanistically, PSMC3 assists in the interaction of AGO2 with the deubiquitylase USP14(ubiquitin specific peptidase 14) and facilitates USP14-mediated deubiquitination of AGO2. As a result, AGO2 is stabilized, which then promotes RNAi.

Conclusion: Our findings demonstrate that PSMC3 plays an essential role in regulating the stability of AGO2 and thus in maintaining effective RNAi.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759854PMC
http://dx.doi.org/10.1186/s11658-022-00411-yDOI Listing

Publication Analysis

Top Keywords

ago2 protein
16
ago2
14
psmc3
12
human argonaute
8
yeast two-hybrid
8
screen ago2-interacting
8
ago2-interacting proteins
8
depletion psmc3
8
psmc3 promotes
4
rnai
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!